Life sciences news
-
Aphea.Bio secures € 70 million Series C Funding, accelerating the company’s commercialisation efforts
Tuesday July 11th 2023
Read more
-
Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2.0 for treatment of congestive heart failure
Monday July 10th 2023
Read more
-
VIB researchers uncover key genetic pathway in leaf development
Tuesday July 4th 2023
Read more
-
Benoît van Den Hove steps up as new CEO of Euronext Brussels
Tuesday July 4th 2023
Read more
-
KU Leuven research generates new insights into the development of and care for 'the little brain' of the gut
Monday July 3rd 2023
Read more
-
AMA issues CPT III code for icometrix’ AI-related brain MRI quantification software
Monday July 3rd 2023
Read more
-
argenx and Zai Lab announce approval of VYVGART® (efgartigimod alfa injection) for generalized myasthenia gravis in China
Friday June 30th 2023
Read more
-
Flen Health receives 1.7 million grant from VLAIO for groundbreaking research on recombinant engineering of wound-healing enzymes
Monday June 26th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
argenx announces U.S. Food and Drug Administration approval of VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) injection for subcutaneous use in generalized myasthenia gravis
Wednesday June 21st 2023
Read more
-
argenx initiates second cohort of Phase 2 ARDA study of empasiprubart in multifocal motor neuropathy
Tuesday June 20th 2023
Read more
-
Sequana Medical wins Best Technology Award for alfapump® at European Mediscience Awards
Friday June 16th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
